Research has shown that EIF5A2 is elevated in multiple cancers, including cervical, ovarian, colorectal, gastric, liver, melanoma, lung, nasopharyngeal, gallbladder, and esophageal squamous cell carcinoma (Wang et al. 2013; Liu et al. 2017; Yang et al. 2009, 2016a, 2016b; Quanico et al. 2017; Zhu et al. 2012; Meng et al. 2015; Tang et al. 2010; Cao et al. 2017; Khosravi et al. 2014, 2016; Chen et al. 2018; Huang et al. 2016; Zheng et al. 2020; Li et al. 2014). The gene discussed is EIF5A2; the disease is cancer.